TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34788694

Group type: EXPERIMENTAL
Intervention: Lefamulin 150 mg IV q12h for 5-7 days
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg IV q24h for 7 days
Number of subjects: 1289

Group type: EXPERIMENTAL
Intervention: Lefamulin 600 mg oral q12h for 5 days
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg oral q24h for 7 days
Number of subjects: 1289
Study: 35233731

Group type: EXPERIMENTAL
Intervention: Inhaled triple therapy (once daily)
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Inhaled dual therapy (twice daily)
Number of subjects: 1801
Study: 33190741

Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 33

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 33
Study: 35092871

Group type: EXPERIMENTAL
Intervention: Nurse-led multidisciplinary team approach
Number of subjects: 235
Study: 33253953

Group type: EXPERIMENTAL
Intervention: Observation group (patients with vascular MCI)
Number of subjects: 28
Study: 35921281

Group type: EXPERIMENTAL
Intervention: Video Meeting Signals (VMS) training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Emoji response buttons training
Number of subjects: 100
Study: 32394658

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (at Baihui (GV 20), Guanyuan (CV 4), Qihai (CV 6), Fengchi (GB 20), Zusanli (ST 36), Sanyinjiao (SP 6)), once a day, 5 times as one course, with 2 days interval between each course, total of 4 courses.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional chemoradiotherapy and symptomatic treatment (control group).
Number of subjects: 80
Study: 34784804

Group type: EXPERIMENTAL
Intervention: Focused shockwave therapy (f‐ESWT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ultrasound guided corticosteroid injection
Number of subjects: 104
Study: 34450050

Group type: EXPERIMENTAL
Intervention: Men (FFR value 0.83 ±0.09)
Number of subjects: 1554

Group type: EXPERIMENTAL
Intervention: Proximal lesions (PLs) in men (FFR value 0.83 ±0.10)
Number of subjects: 1554

Group type: EXPERIMENTAL
Intervention: Primary endpoint in proximal lesions (PLs)
Number of subjects: 1554

Group type: EXPERIMENTAL
Intervention: Deferred lesions
Number of subjects: 1554

Group type: COMPARATOR
Intervention: Non-proximal lesions (non-PLs)
Number of subjects: 1554

Group type: COMPARATOR
Intervention: Revascularized lesions
Number of subjects: 1554
Study: 32466231

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (6 g)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 35838058

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 12
Study: 34948677

Group type: EXPERIMENTAL
Intervention: Garden intervention (Year 1)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Waitlist control (Year 2)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 250
Study: 32439248

Group type: EXPERIMENTAL
Intervention: New nutritional index (NNI)
Number of subjects: 984
Study: 33922683

Group type: EXPERIMENTAL
Intervention: Time-Restricted Eating (TRE) for 12 weeks (8 h eating window)
Number of subjects: 20
Study: 32678041

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 420

Group type: COMPARATOR
Intervention: Solifenacin
Number of subjects: 420

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 420
Study: 34874833

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo/nil
Number of subjects: 253
Study: 34622691

Group type: EXPERIMENTAL
Intervention: External valvuloplasty of the saphenofemoral junction
Number of subjects: 0
Study: 32030845

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided posterior quadratus lumborum block with 0.25% bupivacaine 0.5 mL/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ultrasound-guided ilioinguinal/iliohypogastric nerve block with 0.25% bupivacaine 0.2 mL/kg
Number of subjects: 40
Study: 32368936

Group type: EXPERIMENTAL
Intervention: RehaCom rehabilitation training for 5 weeks (two 60-min sessions per week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 60
Study: 34838980

Group type: EXPERIMENTAL
Intervention: Sarcojoint® 1 package twice a day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vitamin B as placebo (control)
Number of subjects: 66
Study: 33686762

Group type: EXPERIMENTAL
Intervention: Estimand framework application in clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized phase 3 trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estimand framework
Number of subjects: 0
Study: 35357103

Group type: EXPERIMENTAL
Intervention: Insulin addition to total nutrition admixture (TNA)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Noninsulin group
Number of subjects: 208
Study: 32740754

Group type: EXPERIMENTAL
Intervention: Renal Denervation (RDN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 34082090

Group type: EXPERIMENTAL
Intervention: Typbar TCV® co-administered with MR and YF vaccines (Group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inactivated polio vaccine (IPV) co-administered with MR and YF vaccines (Group 2)
Number of subjects: 100
Study: 33044710

Group type: COMPARATOR
Intervention: 15 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450

Group type: COMPARATOR
Intervention: 75 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450

Group type: COMPARATOR
Intervention: 150 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 300 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450

Group type: COMPARATOR
Intervention: 0 mg Cu/kg as Cu-Lys-Glu (control)
Number of subjects: 450
Study: 33149729

Group type: EXPERIMENTAL
Intervention: Short hemostasis (3 hours)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Prolonged hemostasis (8 hours)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Rescue recanalization (only in short hemostasis group)
Number of subjects: 1000
Study: 35296044

Group type: EXPERIMENTAL
Intervention: ECE‐based nutrition and gardening curriculum; nutrition education and food sovereignty curriculum for adults; ECE program menu modifications
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 168
Study: 36429931

Group type: EXPERIMENTAL
Intervention: Elastic Foot Orthosis (EFO)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham Foot Orthosis (SFO)
Number of subjects: 21
Study: 34262967

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Group Walking (GW)
Number of subjects: 91
Study: 32993831

Group type: EXPERIMENTAL
Intervention: Culturally adapted trauma-focused CBT-based guided self-help (CatCBT GSH) in nine sessions over 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 50
Study: 32901234

Group type: EXPERIMENTAL
Intervention: Resin infiltration with Icon (RI; DMG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Remin Pro (RP; VOCO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Complete Care toothpaste (CC; Himalaya)
Number of subjects: 15
Study: 36259302

Group type: EXPERIMENTAL
Intervention: Equicrestal placement of dental implants (Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Subcrestal placement of dental implants (Group II)
Number of subjects: 40
Study: 32367375

Group type: EXPERIMENTAL
Intervention: OPEN (conventional open suture)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MIN (minimally invasive suture)
Number of subjects: 90

Group type: COMPARATOR
Intervention: CONS (conservative treatment)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 32141594

Group type: EXPERIMENTAL
Intervention: Nutrition education curriculum as a core subject
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interest in teaching nutrition
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Adequate nutrition curricular materials
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Training on nutrition education
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Confidence in students' interest in nutrition
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Impact of nutrition education on dietary behaviour
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Comparison of interest and confidence between subjects taught
Number of subjects: 80
Study: 33181730

Group type: EXPERIMENTAL
Intervention: Medicated honey dressing
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard care (routine wound care)
Number of subjects: 99
Study: 35562290

Group type: EXPERIMENTAL
Intervention: Oral appliance therapy
Number of subjects: 314
Study: 32720552

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment (3 treatments at monthly intervals)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Watchful waiting (no treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 30
Study: 36012990

Group type: EXPERIMENTAL
Intervention: 5-day fasting followed by 10 weeks of lifestyle modification
Number of subjects: 145

Group type: COMPARATOR
Intervention: 10 weeks of lifestyle modification only
Number of subjects: 145
Study: 36494723

Group type: EXPERIMENTAL
Intervention: MOHMQuit intervention
Number of subjects: 4000
Study: 34385236

Group type: EXPERIMENTAL
Intervention: Point-of-care (PoC) testing and immediate treatment of curable STIs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 0
Study: 32954487

Group type: EXPERIMENTAL
Intervention: 800 mg/day of pharmaceutical-grade chondroitin sulfate (CS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 0
Study: 33926446

Group type: EXPERIMENTAL
Intervention: Insulin glargine U300 (IGlar‐300)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Insulin degludec U100 (IDeg‐100)
Number of subjects: 23
Study: 33046094

Group type: EXPERIMENTAL
Intervention: Medicines and Alcohol Consultation (MAC) delivered by trained community pharmacists (n=5) during Medicine Use Review (MUR) and New Medicine Service (NMS) consultations.
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group provided usual MUR/NMS services without the MAC intervention (n=5).
Number of subjects: 260
Study: 35164805

Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention with a Viral Prescription Pad and emphasis on harms of antibiotics (OH Trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention with variations (PHO Trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not receiving the intervention)
Number of subjects: 0
Study: 32660932

Group type: EXPERIMENTAL
Intervention: Cue utilisation assessment prior to the rail control task
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Situational awareness assessed using SAGAT queries during the rail control task
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Simulated rail control task under varying task demands
Number of subjects: 55
Study: 36002548

Group type: EXPERIMENTAL
Intervention: 1250 mg of β-nicotinamide mononucleotide (β-NMN) administered orally once daily for up to 4 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 34290065

Group type: EXPERIMENTAL
Intervention: Non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 140
Study: 32106827

Group type: EXPERIMENTAL
Intervention: Systematic training in the use of the Guide to Action Tool for Care Homes
Number of subjects: 6

Group type: COMPARATOR
Intervention: New falls prevention initiatives implemented outside the study
Number of subjects: 6
Study: 616782726

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over left dorsolateral prefrontal cortex, 20 minutes, 2 mA, for 10 sessions
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 44
Study: 35278903

Group type: EXPERIMENTAL
Intervention: Ficus septica exudate
Number of subjects: 150

Group type: COMPARATOR
Intervention: Savlon antiseptic cream
Number of subjects: 150

Group type: COMPARATOR
Intervention: Soap and water treatment
Number of subjects: 150
Study: 33444781

Group type: EXPERIMENTAL
Intervention: CVRS (Cardiovascular Risk Service) provided by remote clinical pharmacists
Number of subjects: 325

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 325
Study: 33175326

Group type: EXPERIMENTAL
Intervention: Pure Portland cement
Number of subjects: 136

Group type: COMPARATOR
Intervention: Formocresol
Number of subjects: 136
Study: 33049713

Group type: EXPERIMENTAL
Intervention: Five-protein risk signature developed from the discovery cohort.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HER3_pY1289 staining intensity.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HER3 suppression.
Number of subjects: 0
Study: 36113531

Group type: EXPERIMENTAL
Intervention: One dose of Cervarix
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Two doses of Cervarix
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Three doses of Cervarix
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: One dose of Gardasil-9
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Two doses of Gardasil-9
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Three doses of Gardasil-9
Number of subjects: 930

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 930
Study: 33626501

Group type: EXPERIMENTAL
Intervention: Foam roller for 30 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Foam roller for 2 minutes
Number of subjects: 40
Study: 33072214

Group type: EXPERIMENTAL
Intervention: ProTaper Universal files (Dentsply Maillefer) used in rotary preparation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Failures during rotary preparation
Number of subjects: 50
Study: 35501569

Group type: EXPERIMENTAL
Intervention: Pelvic relaxation and sexual counseling based on the IMB model (4 sessions)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine treatment protocol (Control)
Number of subjects: 34
Study: 33271509

Group type: EXPERIMENTAL
Intervention: Moral intervention
Number of subjects: 303

Group type: COMPARATOR
Intervention: Educational intervention
Number of subjects: 303
Study: 32603336

Group type: EXPERIMENTAL
Intervention: Osteopathic techniques (thoracic thrust, sternal pump technique, diaphragm stretching)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Soft tissue therapy (STT) techniques for the masseter muscle
Number of subjects: 30
Study: 35723225

Group type: EXPERIMENTAL
Intervention: Triple therapy (metformin/pioglitazone/exenatide)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional therapy (metformin/insulin/glipizide)
Number of subjects: 46
Study: 33276817

Group type: EXPERIMENTAL
Intervention: Acupotomy combined with PCA
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional PCA
Number of subjects: 70
Study: 32773637

Group type: EXPERIMENTAL
Intervention: ESRT (Enhanced Stress Resilience Training)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study: 35605867

Group type: EXPERIMENTAL
Intervention: 1-day pulse delivery of glyphosate (Rodeo)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous delivery of glyphosate (Rodeo)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Both pulse and continuous delivery methods
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Passive samplers (POCIS-MIP)
Number of subjects: 7
Study: 34684508

Group type: EXPERIMENTAL
Intervention: Swank diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wahls diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wahls diet (including supplements)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both diets (including supplements)
Number of subjects: 0
Study: 35538539

Group type: EXPERIMENTAL
Intervention: Tanimilast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 0
Study: 33308325

Group type: EXPERIMENTAL
Intervention: Combined model (2 CT signs and 2 texture parameters)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Clinical model
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: CT model
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Texture model
Number of subjects: 172
Study: 36074965

Group type: EXPERIMENTAL
Intervention: Blessed TRI 360TM capsule (Biofield Energy Treated Proprietary Dietary Supplement) taken twice a day (morning and evening)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo control (no treatment/capsule)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Blessed TRI 360TM capsule
Number of subjects: 77
Study: 33215362

Group type: EXPERIMENTAL
Intervention: Low-Calorie Ketogenic Diet (LCKD)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard Low-Calorie Diet (LCD)
Number of subjects: 48
Study: 33705355

Group type: EXPERIMENTAL
Intervention: 1,000 IU daily vitamin D3 supplementation
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 3,000 IU daily vitamin D3 supplementation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 69
Study: 34737843

Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 17% EDTA and 2% CHX
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 7% maleic acid (MA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 7% MA and 2% CHX
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: EndoREZ
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Tech BioSealer Endo
Number of subjects: 160
Study: 36396999

Group type: EXPERIMENTAL
Intervention: 100 mg L-1 SiO2-NPs
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: SiO2-NPs treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Drought stress (control)
Number of subjects: 2
Study: 33737088

Group type: EXPERIMENTAL
Intervention: Acute exercise (30 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 20
Study: 36524101

Group type: EXPERIMENTAL
Intervention: Leriglitazone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 34811384

Group type: EXPERIMENTAL
Intervention: Weekly interactive text messages asking 'How are you?' until 24 months postpartum.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group receiving routine PMTCT care without text messages.
Number of subjects: 600
Study: 33895468

Group type: EXPERIMENTAL
Intervention: Stair walking
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: RFID devices
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Bluetooth and RFID readers
Number of subjects: 29
Study: 34097130

Group type: EXPERIMENTAL
Intervention: normobaric hypoxia (13% FiO2) + NO3- (HNO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: normobaric hypoxia + placebo (HPL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: normoxia (20.9% FiO2) + placebo (CON)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Repeated-sprint training (RSH)
Number of subjects: 30
Study: 32559503

Group type: EXPERIMENTAL
Intervention: Pain reduction
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Demographic and clinical factors
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Covariates (treatment group, time, baseline depression severity)
Number of subjects: 309
Study: 36107611

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 34016453

Group type: EXPERIMENTAL
Intervention: cTC + bevacizumab
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: ddTC + bevacizumab
Number of subjects: 122

Group type: COMPARATOR
Intervention: cTC
Number of subjects: 122

Group type: COMPARATOR
Intervention: ddTC
Number of subjects: 122
Study: 34162699

Group type: EXPERIMENTAL
Intervention: BeSMART intervention
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: BeSMART + physician review
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control (tobacco smoke videos and handouts)
Number of subjects: 225
Study: 34826125

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10) supplementation for 4 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 34162720

Group type: EXPERIMENTAL
Intervention: Dixon fat‐water imaging (quantitative fat‐water MRI)
Number of subjects: 24
Study: 32289676

Group type: EXPERIMENTAL
Intervention: Inhibitory rTMS (continuous theta-burst stimulation paradigm at 50 Hz for 40s)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 52
Study: 36089529

Group type: EXPERIMENTAL
Intervention: Darolutamide 600 mg twice daily
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1509
Study: 33185847

Group type: EXPERIMENTAL
Intervention: da Vinci training simulator (group 1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: computer‐based cognitive training (group 2)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group without training (group 3)
Number of subjects: 25
Study: 32729275

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon angioplasty (DBA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Plain balloon angioplasty (PBA)
Number of subjects: 39
Study: 36513447

Group type: EXPERIMENTAL
Intervention: Fat-based formula (group A: protein 20%, olive and sunflower oil 45%, carbohydrate 35%)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Fat-based formula (group A)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (carbohydrate-based formula: protein 20%, fat 30%, carbohydrate 50%)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group and group B
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 93